← Leaderboards
Joaquin Lopez Herraiz
Sloan-Kettering Inst Can Research
$321,939
Attributed
$1,287,757
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $659.9K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$1,287,757 · 1
By mechanism
R01$1,287,757 · 1
Top collaborators
- Jan Grimm2 shared
- Vladimir Ponomarev2 shared
- Jose Manuel Udias Moinelo2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jason S Lewis$26,024,327
- Brian Matthew Zeglis$6,881,872
- Jan Grimm$17,140,928
- Michelle S Bradbury$7,087,200
- Charles L Sawyers$34,701,646
Others in their field
Other Rising Stars on “Advanced Malignant Neoplasm”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Channapatna S. Prakash · Tuskegee University$7,931,772
- Paola A Ramos · Mayo Clinic Rochester$7,298,203
- Erin Leahy · Icf, Inc., Llc$6,884,676
Research focus
Advanced Malignant NeoplasmAffectAmerican Society Of Clinical OncologyAnimalsAntibodiesBar CodesBiologicalBiopsyCancer BiologyCancer ImagingCancer PatientCancer TherapyCd8b1 GeneCd8-Positive T-LymphocytesCellsCell TherapyCheckpoint InhibitionChimeric Antigen Receptor T CellsClinical CareClinical ImagingClinically RelevantCollimatorColorActionable Mutation